[HTML][HTML] Summary of the evidence on modifiable risk factors for cognitive decline and dementia: a population-based perspective
M Baumgart, HM Snyder, MC Carrillo, S Fazio… - Alzheimer's & …, 2015 - Elsevier
An estimated 47 million people worldwide are living with dementia in 2015, and this number
is projected to triple by 2050. In the absence of a disease-modifying treatment or cure …
is projected to triple by 2050. In the absence of a disease-modifying treatment or cure …
Risk factors associated with the onset and progression of Alzheimer's disease: A systematic review of the evidence
M Hersi, B Irvine, P Gupta, J Gomes, N Birkett… - Neurotoxicology, 2017 - Elsevier
A systematic review was conducted to identify risk factors associated with the onset and
progression of Alzheimer's disease (AD). Moderate and high quality systematic reviews …
progression of Alzheimer's disease (AD). Moderate and high quality systematic reviews …
The projected effect of risk factor reduction on Alzheimer's disease prevalence
Summary At present, about 33· 9 million people worldwide have Alzheimer's disease (AD),
and prevalence is expected to triple over the next 40 years. The aim of this Review was to …
and prevalence is expected to triple over the next 40 years. The aim of this Review was to …
Body mass index in midlife and late‐life as a risk factor for dementia: a meta‐analysis of prospective studies
KJ Anstey, N Cherbuin, M Budge, J Young - Obesity reviews, 2011 - Wiley Online Library
The relationship between body mass index (BMI)(in midlife and late‐life) and dementia was
investigated in meta‐analyses of 16 articles reporting on 15 prospective studies. Follow‐ups …
investigated in meta‐analyses of 16 articles reporting on 15 prospective studies. Follow‐ups …
Angiotensin II revisited: new roles in inflammation, immunology and aging
That the renin–angiotensin system (RAS) is involved in regulation of blood pressure,
vasoconstriction, sodium intake and potassium excretion is well established. Studies in the …
vasoconstriction, sodium intake and potassium excretion is well established. Studies in the …
Cardiovascular risk factors promote brain hypoperfusion leading to cognitive decline and dementia
JC de La Torre - Cardiovascular psychiatry and neurology, 2012 - Wiley Online Library
Heart disease is the major leading cause of death and disability in the world. Mainly
affecting the elderly population, heart disease and its main outcome, cardiovascular …
affecting the elderly population, heart disease and its main outcome, cardiovascular …
Antihypertensive drugs, prevention of cognitive decline and dementia: a systematic review of observational studies, randomized controlled trials and meta-analyses …
L Rouch, P Cestac, O Hanon, C Cool, C Helmer… - CNS drugs, 2015 - Springer
Background Chronic hypertension, particularly midlife high blood pressure, has been
associated with an increased risk for cognitive decline and dementia. In this context …
associated with an increased risk for cognitive decline and dementia. In this context …
Cognitive function, dementia and type 2 diabetes mellitus in the elderly
MWJ Strachan, RM Reynolds, RE Marioni… - Nature Reviews …, 2011 - nature.com
Increasing numbers of people are developing type 2 diabetes mellitus, but interventions to
prevent and treat the classic microvascular and macrovascular complications have …
prevent and treat the classic microvascular and macrovascular complications have …
Brain renin-angiotensin—a new look at an old system
JW Wright, JW Harding - Progress in neurobiology, 2011 - Elsevier
The classic renin-angiotensin system (RAS) is described as a circulating hormone system
focused on cardiovascular and body water regulation, with angiotensin II as its major …
focused on cardiovascular and body water regulation, with angiotensin II as its major …
The brain renin–angiotensin system: a diversity of functions and implications for CNS diseases
JW Wright, JW Harding - Pflügers Archiv-European Journal of Physiology, 2013 - Springer
The classic renin–angiotensin system (RAS) was initially described as a hormone system
designed to mediate cardiovascular and body water regulation, with angiotensin II as its …
designed to mediate cardiovascular and body water regulation, with angiotensin II as its …